Skip to content

Andrew J. Schwab, Director at Skye Bioscience, sold SKYE on Sep 16, 2026

Data as of Oct 16

▼ SELL$62.3K32,607 shares at $1.91Andrew J. Schwab DirectorSKYE Skye Bioscience, Inc.
Watch SKYE
Traded
Sep 16, 2026
Disclosed
Sep 18, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Andrew J. Schwab, Director at Skye Bioscience, sold SKYE on Sep 16, 2026TRADEDDISCLOSED
SKYESimilar stocks (XLV — its sector index fund), rebased to SKYE's price on the disclosure day
SKYE since disclosure
−12.2%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund

Change in closing price from Sep 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$2.5Kdisclosed Sep 18 · filed 2 days after the trade

See every trade on SKYE →